Skip to content
2000
Volume 16, Issue 4
  • ISSN: 1574-888X
  • E-ISSN: 2212-3946

Abstract

COVID-19 pandemic is a global health crisis of the 21st Century. There are currently no approved vaccines and no particular anti-viral treatment for coronavirus disease. As COVID-19 has a broad range of illnesses, it is necessary to find a safe and effective therapeutic method for COVID-19. An attractive approach for treating COVID-19 is cell therapy. Cell therapy aims to inject new and healthy stem cells into a patient’s body, to repair the damaged cells and tissues. Stem cell therapy is one of the most studied and important approaches in the treatment of COVID-19 these days. The significant clinical outcome was observed by the adoptive transfer of stem cells, specifically mesenchymal stem cells. This study reviews the characteristics of stem cells and clinical trials that have used stem cells in treating COVID-19.

Loading

Article metrics loading...

/content/journals/cscr/10.2174/1574888X15666201012165700
2021-05-01
2025-05-03
Loading full text...

Full text loading...

/content/journals/cscr/10.2174/1574888X15666201012165700
Loading

  • Article Type:
    Review Article
Keyword(s): cell therapy; clinical trials; coronavirus; COVID-19; mesenchymal stem cells; β-CoV
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test